Collectively, cities take up a relatively tiny amount of land on the earth, yet they emit 72 percent of greenhouse gas emissions. Clearly, cities need to be at the center of any broad effort to reduce climate change. In Greenovation, the eminent urban policy scholar Joan Fitzgerald argues that too many cities are only implementing random acts of greenness that will do little to address the climate crisis. She instead calls for "greenovation"--using the city as a test bed for adopting and perfecting green technologies for more energy--efficient buildings, transportation, and infrastructure more broadly. Fitzgerald contends that while many city mayors cite income inequality as a pressing problem, few cities are connecting climate action and social justice-another aspect of greenovation. Focusing on the biggest producers of greenhouse gases in cities, buildings, energy and transportation, Fitzgerald examines how greenovating cities are reducing emissions overall and lays out an agenda for fostering and implementing urban innovations that can help reverse the path toward irrevocable climate damage. Drawing on interviews with practitioners in more than 20 North American and European cities, she identifies the strategies and policies they are employing and how support from state, provincial and national governments has supported or thwarted their efforts. A uniquely urban-focused appraisal of the economic, political, and social debates that underpin the drive to "go green," Greenovation helps us understand what is arguably the toughest policy problem of our era: the increasing impact of anthropocentric climate change on modern social life.

"This book is meant to stimulate awareness and discussion around topics of sustainability and innovation."--Page 113.

With three Nobel Laureates contributing to this invaluable collection of high-quality articles, carefully selected from the highly praised R.A. Meyer's Encyclopedia, these two volumes cover a wide range of topics in protein research. Clearly divided into sections on structure, modeling, expression, analysis and others, the chapters are designed to aid readers of all levels of expertise: Each chapter includes a glossary of the most important keywords, a concise summary of the article concerned and comprehensive references for further reading. Similarly, the uniform structure of the articles makes them very easy to use, resulting in a ready reference for molecular and cell biologists, biochemists, biophysicists, and biotechnologists, as well as those working in the pharmaceutical and biotechnological industries.

Authoritative guide to the principles, characteristics, engineering aspects, economics, and applications of disposables in the manufacture of biopharmaceuticals The revised and updated second edition of Single-Use Technology in Biopharmaceutical Manufacture offers a comprehensive examination of the most-commonly used disposables in the manufacture of biopharmaceuticals. The authors—noted experts on the topic—provide the essential information on the principles, characteristics, engineering aspects, economics, and applications. This authoritative guide contains the basic knowledge and information about disposable equipment. The author also discusses biopharmaceuticals’ applications through the lens of case studies that clearly illustrate the role of manufacturing, quality assurance, and environmental influences. This updated second edition revises existing information with recent developments that have taken place since the first edition was published. The book also presents the latest advances in the field of single-use technology and explores topics including applying single-use devices for microorganisms, human mesenchymal stem cells, and T-cells. This important book: • Contains an updated and end-to-end view of the development and manufacturing of single-use biologics • Helps in the identification of appropriate disposables and relevant vendors • Offers illustrative case studies that examine manufacturing, quality assurance, and environmental influences • Includes updated coverage on cross-functional/transversal dependencies, significant improvements made by suppliers, and the successful application of the single-use technologies Written for biopharmaceutical manufacturers, process developers, and biological and chemical engineers, Single-Use Technology in Biopharmaceutical Manufacture, 2nd Edition provides the information needed for professionals to come to an easier decision for or against disposable alternatives and to choose the appropriate system.

Collectively, cities take up a relatively tiny amount of land on the earth, yet emit 72 percent of greenhouse gas emissions. Clearly, cities need to be at the center of any broad effort to reduce climate change. In Greenovation, the eminent urban policy scholar Joan Fitzgerald argues that too many cities are only implementing random acts of greenness that will do little to address the climate crisis. She instead calls for "greenovation"--using the city as a test bed for adopting and perfecting green technologies for more energy--efficient buildings, transportation, and infrastructure more broadly. Further, Fitzgerald contends that while many city mayors cite income inequality as a pressing problem, few cities are connecting climate action and social justice-another aspect of greenovation. Focusing on the biggest producers of greenhouse gases in cities, buildings, energy and transportation, Fitzgerald examines how greenovating cities are reducing emissions overall and lays out an agenda for fostering and implementing urban innovations that can help reverse the path toward irrevocable climate damage. Drawing on interviews with practitioners in more than 20 North American and European cities, she identifies the strategies and policies they are employing and how support from state, provincial and national governments has supported or thwarted their efforts. A uniquely urban-focused appraisal of the economic, political, and social debates that underpin the drive to "go green," Greenovation helps us understand what is arguably the toughest policy problem of our era: the increasing impact of anthropocentric climate change on modern social life.

This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact.

With its focus on industrial pharmaceutical research, written by international experts from the industry, this book fills in a gap in the existing literature. It reflects the combination of such pharmaceutical interests as drug delivery, drug targeting, quality and safety management, drug approval and regulation, patenting issues and biotechnology fundamentals. Thus it provides practitioners in pharmaceutical biotechnology with all the relevant information from the shelf. The first part offers a comprehensive survey and review of the rapidly increasing array of biopharmaceuticals derived from the molecular biological approaches now widely available. This is followed by an extra section devoted to the very critical patenting and drug regulation issues. The whole is rounded off by detailed monographs of biotechnologically developed drugs that are already on the market. With a foreword of by Robert Langer, Kenneth J Germeshausen Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology. In 2002, he received the Charles Stark Draper Prize, the highest recognition for an engineer. Professor Langer is member of all three national academies - the Institute of Medicine, the National Academy of Engineering, and the National Academy of Sciences: "The book attempts to provide a balanced view of the biotechnological industry and the number of experts from industry sharing their knowledge and experience with the audience gives the book an outstanding value. All contributors provide with each chapter an up-to-date review on key topics in pharmaceutical biotechnology. This work is not only a valuable tool for the industrial expert but also for all pharmacists and scientists from related areas who wish to work with biotech drugs."